Text Size

Ureteral Stent Length and Patient Symptoms

This study has been terminated.
(Because no staff to consent or enroll subjects)
Sponsor:
Information provided by (Responsible Party):
John G Pattaras, MD, Emory University
ClinicalTrials.gov Identifier:
NCT00288457
First received: February 6, 2006
Last updated: March 27, 2012
Last verified: March 2012
History of Changes
  Purpose

The Study of whether or not Ureteral Stent Length affects patient comfort after electro-shock wave treatment for kidney stones.


Condition Intervention
Kidney Stones
 Device: Ureteral Stent

Study Type: Observational
Study Design: Time Perspective: Prospective

Resource links provided by NLM:

MedlinePlus related topics: Kidney Stones
U.S. FDA Resources

Further study details as provided by Emory University:

Enrollment: 1
Study Start Date: February 2006
Intervention Details:
    Device: Ureteral Stent
    Ureteral stents are not investigatory but rather part of standard of care. In this study, we were interested in having patients fill out pre and post-operative questionnaires so that we could compare their symptoms with the length of their ureter and the stent placed.
Detailed Description:

Patients undergoing electro shock wave for treatment of kidney stones are randomized to long or short stent length after signing an informed consent prior to their surgery. They keep a pain diary and medication diary for a two week period after the stent is placed. These are turned in at the two week post-op visit. Patients also complete a quality of life and urinary symptom score questionnaire pre and post operatively.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Male or female over 18 years of age, will be receiving electro-shock wave therapy for kidney stones

Criteria

Inclusion Criteria: Male or female over 18 years of age, will be receiving electro-shock wave therapy for kidney stones -

Exclusion Criteria:Under 18 years of age, inability to give informed consent

-

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00288457

Sponsors and Collaborators
Emory University
Investigators
Principal Investigator: John G Pattaras, MD Emory University
  More Information

No publications provided

Responsible Party: John G Pattaras, MD, Associate Professor, Emory University
ClinicalTrials.gov Identifier: NCT00288457     History of Changes
Other Study ID Numbers: 758-2003
Study First Received: February 6, 2006
Last Updated: March 27, 2012
Health Authority: United States: Food and Drug Administration

Additional relevant MeSH terms:
Kidney Calculi
Nephrolithiasis
Kidney Diseases
Urologic Diseases
 Urolithiasis
Urinary Calculi
Calculi
Pathological Conditions, Anatomical

ClinicalTrials.gov processed this record on May 19, 2013